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a stable trait in CD patients and also studied if this was influenced by a genetic predisposition.
Materials and methods: From a cohort of 466 CD patients who underwent a bowel resection
in the period between 1-1-1991 and 31-12-2007 we identified 88 patients with two or
more bowel resections in that time period (55,7% male, median [interquartile range, IQR]
age at diagnosis 20,92 [17,05-28,51] years, median [IQR] age at first surgery 32,81 [22,93-
41,64] years, median [IQR] time between surgeries 5,76 [3,8-8,96] years. Revision of patho-
logy slides (average of 10 slides per resection specimen) was performed to classify patients
as granuloma positive or negative at each surgery. Epithelioid granuloma was defined as a
well circumscribed collection of at least five epithelioid macrophages (activated histiocytes
with a homogenous eosinophilic cytoplasm) with or without multinucleated giant cells. All
patients were genotyped for 76 selected SNPs in human homologues of yeast autophagy
(Atg) genes, using the Sequenom MassARRAY® platform. Results: In 71,6% of patients (n=
63) no change in granuloma status was observed with subsequent surgeries. Among these
patients, 58,7% were classified as granuloma positive and 41,3% as granuloma negative.
We could not find significant differences in age at first surgery, disease duration to first
surgery or time between surgeries between patients whose granuloma status did or did not
change. Genotype and allele frequencies for the studied polymorphisms did not differ
between patients whose granuloma status did or did not change. Conclusions: Granuloma
formation appears to be a stable trait in the majority of CD patients. This raises the hypothesis
that an underlying intrinsic defect may make a patient prone to develop granulomas. Genetic
variants in autophagy genes do not seem to play a role in this resepect.
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Milano, Francesco Laterza, Matteo Neri
Biofeedback (BF) is an effective treatment for pelvic floor dyssynergia (PFD), that has no
adverse effects but the time necessary to achieve a sustained response in individual patients
and the appropriate number of training sessions is impredictable. Probiotics have been
shown to improve altered bowel habits and bloating in IBS, but it is unknown whether they
can be of any help in patients with obstructed defecation. Aim of this pilot study is to
compare BF to a BF + probiotic in patients suffering from pelvic floor disorders Methods:
63 patients with chronic, severe PFD, diagnosed by anorectal manometry and defecography,
were first treated with 20 g/day fiber plus enemas or suppositories up to twice weekly.Nonre-
sponders were randomized to either 5 weekly biofeedback sessions (n = 24) or to biofeedback
plus a mixture of 8 different bacterial strains (VSL#3) with a concentration of 10 9 colony-
forming units per day for five weeks (n= 16) Satisfaction with treatment, symptoms of
constipation, and pelvic floor physiology were assessed during treatment at 6 and 12 months.
At all visits constipation-related symptoms were measured by means of a diary evaluating
number of evacuation, satisfactory defecation, obstruction of evacuation, digital evacuation,
bloating. RESULTS: The rectoanal inhibitory reflex (RAIR) initially showing incomplete
relaxation, became normal by the end of the rehabilitation period. All RAIR parameters
significantly improved post-treatment in both groups in comparison to baseline (47%vs
76% in BF group and 39% vs 72% in BF+probiotics, P < 0.001), but no differences were
observed between groups. Rectal sensation and compliance did not change after rehabilitation
with or without probiotic. During treatment constipation -related symptoms significantly
improved in both groups at the end of the 5-week treatment ( BF 58% vs BF+probiotic
87%) , although the treatment group BF plus probiotic achieved significant improvement
for bloating, satisfactory defecation and number of evacuation at two weeks in comparison
to the baseline period (p<0.05). Anorectal physiology features were unchanged at 6 and 12
months in both groups. Conclusion : Biofeedback is an effective treatment for PFD and its
efficacy on symptoms can be heightened by the simultaneous addition of probiotics.
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Oral Mucosa Patch Test: A New Tool to Identify and Study the Alimentary
Intolerance to Nickel-Containing Foods
Antonio Picarelli, Anna Vallecoccia, Marco Di Tola, Mirella Magrelli, Daniela De Nitto,
Valerio Libanori, Annarita Saponara, Francesca Paris, Elisabetta Scali, Marta Carlesimo,
Alfredo Rossi
Background & aim: Nickel-exposure through the skin may cause an allergic contact derma-
titis, for which the gold standard for diagnosis is the epicutaneous patch test. Similarly, nickel-
exposure via intestinal mucosa can be able to induce symptoms as diarrhoea, abdominal pain
and swelling. Our aim was to investigate the relationship between these symptoms and
nickel-intake by an oral mucosa patch test, described for the first time in the present study.
Methods: Sixty-seven patients with intestinal symptoms referable to the ingestion of nickel-
containing foods were included in the study. Each patient underwent to epicutaneous and
oral mucosa patch tests to nickel. All patients presenting a positive oral mucosa patch test
were submitted to a nickel-poor diet and monitored over time. Results: At the epicutaneous
patch test, local lesions were observed in 27/67 (40.3%) patients while, after oral mucosa
patch test, local lesions (erythema, oedema and vesicles) and/or general reaction (itching
and dermographia) were observed in 40/67 (59.7%) patients evaluated. All patients presenting
a positive oral mucosa patch test showed a relapse of symptoms with the same latency
observable after nickel-containing foods ingestion. Inversely, 35/40 (87.5%) patients positive
at the oral mucosa patch test showed an improvement in their symptoms after two months
of nickel-poor diet. Conclusions: Our data show that the oral mucosa patch test could be
used to identify and to study nickel-containing foods alimentary intolerance and, at the
same time, it seems to be suitable to redefine this pathological condition as “allergic contact
mucositis”. Moreover, we can see that a nickel-poor diet may be useful to improve the
clinical picture, as well as to obtain the restoration of well-being in the affected patients.
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Altered Colonic Metabolite Fingerprint in Chronic Kidney Disease As
Compared to Healthy State
Vicky De Preter, Björn Meijers, Bert R. Bammens, Paul J. Rutgeerts, Pieter Evenepoel,
Kristin Verbeke
Introduction: Chronic kidney disease (CKD) is characterised by changes in biochemical and
physiological functions. Although the exact pathogenic mechanisms for these changes are
still largely unknown, it is accepted that there is a progressive retention of some compounds
that are normally excreted by the kidney. An important subgroup of retention solutes
originates from protein fermentation in the colon. Accumulation of fermentation metabolites
in CKD is associated with further deterioration of renal function, increased overall mortality
and increased incidence of cardiovascular disease. While colonic fermentation solutes clearly
affect the progression and prognosis of CKD, it is unclear whether CKD itself interferes with
colonic protein fermentation. The aim of this study was to compare the faecal volatile
compounds (VOC) fingerprint between CKD patients and healthy subjects. Methods: Faecal
samples were obtained from 55 healthy subjects and 12 CKD patients. A purge-and-trap
sample preparation system, coupled on line to a GC-MS (time-of-flight) was applied to analyse
the VOC. AMDIS software was applied to extract purified mass spectra from overlapping
components. Cluster analysis was used to compare the metabolic profiles. Statistics were
done using SPSS 15.0. Results: A total of 237 different VOC were identified in the faecal
samples with an average of 62 ± 8 VOC per control and 51 ± 4 per CKD patient. Five VOC
were found in all analyzed samples: acetone, benzaldehyde, 4-methyl phenol, 2-methyl
propanal and toluene. VOC fingerprints clearly clustered in 2 groups, discriminating between
CKD and controls. Subsequently, we identified twelve VOC, which significantly differed
between healthy subjects and CKD patients. Conclusions: We report the first analysis of
fermentation metabolites in a cohort of CKD patients versus healthy volunteers. These
findings suggest that CKD interferes with bacterial colonic protein fermentation. In turn,
retained protein fermentation metabolites adversely affect outcomes of CKD patients. Com-
bined, these data suggest a complex colo-renal interplay which might provide new therapeutic
targets for CKD.
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Duodenal Adenomas in Nonpolyposis Syndrome Patients Are Not Associated
to Colorectal Neoplasia
Dilka I. Gonzalez-Ortiz, Doris H. Toro, Johanna Bigio, Marcia R. Cruz-Correa, Carol L.
Torres-Cotto
Background: Duodenal adenomas are extremely common in patients with familial aden-
omatous polyposis. In the general population, sporadic duodenal adenomas are an uncom-
mon finding. Among individuals with duodenal adenomas, the development of concurrent
colonic adenomas has been proposed, suggesting a diffuse gastrointestinal mucosa proliferat-
ive process and thus surveillance with colonoscopy may be warrant. Methods: A total of
10,666 upper endoscopies were performed from January 1997 to July 2007. All patients
with a histological diagnosis of duodenal adenomas were retrospectively reviewed and
identified as cases. Those with history of familial adenomatous polyposis, hereditary non
polyposis colorectal cancer syndrome or duodenal carcinoma were excluded. Four age-
matched control subjects having both colonoscopy and endoscopy during the same period
were randomly selected for each case. Association of duodenal polyposis and colonic aden-
omas was calculated with two sample proportions and chi square using SPSS. Results: In
the 10-year period, we identified 21 patients with duodenal adenomas, meeting the inclusion
criteria. All were males with a mean age of 67 years (range: 45-86 years). The most common
indication for upper gastrointestinal endoscopy (EGD) among cases was abnormal imaging
(47.6%), while for the 84 age-matched controls the most common indication was gastrointes-
tinal bleeding (29.8%). Most adenomas were located in the second portion of the duodenum
(63%), had a mean size of 5 mm (range 1-21 mm), and 4 of 21 (18%) of adenomas were
classified as harboring high grade dysplasia. The prevalence of sporadic duodenal adenomas
was 0.2%. Nine of 21 (42.8%) cases and 38 of 84 (45%) of the age-matched controls (p=
0.21) were found with concurrent colonic adenomas. There was no significant statistical
association between presence of duodenal polyposis and anemia, use of PPI, smoking,
alcohol, BMI or medical history of diabetes mellitus. Conclusion: Prevalence of duodenal
polyposis was low, although a high number of polyps exhibited high grade dysplasia.
There was no statistically significant association between nonfamilial duodenal polyposis
and colorectal adenomas. Our observations do not support early colonoscopy surveillance
for patients with duodenal polyposis and suggest that the presence of duodenal adenomas
is a sporadic finding and unrelated to colorectal neoplasia.
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Gastrointestinal Complications in Patients Supported with Ventricular Assist
Devices
Muhammad A. Siddiqui, Mark S. Slaughter, Rogelio G. Silva
Purpose: Left Ventricular Assist Devices (LVADs) have become the standard of care for end-
stage heart failure as either Bridge to Transplantation (BTT) or Destination Therapy (DT).
We reviewed GI complications and their treatment in patients supported with a LVAD. To
our knowledge, this is the largest series presented to date. Methods: From 2003-2008, 86
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